Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers

NCT01237028 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Calcitriol

Sponsor

Yonsei University